| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.058 | 0.5 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.032 | 0.5 |